Form 8-K - Current report:
SEC Accession No. 0001193125-12-225702
Filing Date
2012-05-10
Accepted
2012-05-10 16:32:36
Documents
8
Period of Report
2012-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d349837d8k.htm 8-K 21619
2 UNDERWRITING AGREEMENT d349837dex11.htm EX-1.1 183104
3 OPINION OF COOLEY LLP d349837dex51.htm EX-5.1 10319
4 PRESS RELEASE d349837dex991.htm EX-99.1 7165
5 PRESS RELEASE d349837dex992.htm EX-99.2 8746
6 GRAPHIC g349837g27k00.jpg GRAPHIC 6415
7 GRAPHIC g349837g74y92.jpg GRAPHIC 16193
8 GRAPHIC g349837g74z98.jpg GRAPHIC 14649
  Complete submission text file 0001193125-12-225702.txt   283863
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 12830752
SIC: 2834 Pharmaceutical Preparations